Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

被引:0
|
作者
Hamadeh, Issam [1 ]
Shekarkhand, Tala [1 ]
Rueda, Colin [1 ]
Firestone, Ross [1 ]
Wang, Alice [1 ]
Korde, Neha [1 ]
Hultcrantz, Malin [1 ]
Lesokhin, Alexander [1 ]
Mailankody, Sham [1 ]
Hassoun, Hani [1 ]
Shah, Urvi [1 ]
Maclachlan, Kylee [1 ]
Patel, Dhwani [1 ]
Shah, Gunjan [1 ]
Scordo, Michael [1 ]
Lahoud, Oscar [1 ]
Chung, David [1 ]
Landau, Heather [1 ]
Giralt, Sergio [1 ]
Usmani, Saad [1 ]
Tan, Carlyn Rose [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-013
引用
收藏
页码:S40 / S40
页数:1
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
    Lal, Bhavesh Mohan
    Pandey, Toshali
    Alzubi, Marah
    Alrawabdeh, Jawad
    Shaughnessy Jr, John D.
    Zhan, Fenghuang
    Siegel, Eric
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Al Hadidi, Samer
    BLOOD, 2024, 144 : 2405 - 2406
  • [32] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
    Li, Hujun
    Yin, Lingling
    Wang, Ying
    Wang, Xiangmin
    Shi, Ming
    Cao, Jiang
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2215 - 2218
  • [33] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [34] Impact of Daratumumab Refractoriness on Clinical Outcomes Following CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma
    Costa, Bruno
    Rajeeve, Sridevi
    Jurgens, Eric
    Nishimura, Noriko
    Farzana, Tasmin
    Firestone, Ross
    Miller, Kevin
    Lesokhin, Alexander
    Shah, Gunjan
    Korde, Neha
    Tan, Carlyn
    Chung, David
    Landau, Heather
    Scordo, Michael
    Hassoun, Hani
    Maclachlan, Kylee
    Shah, Urvi
    Hultcrantz, Malin
    Hamadeh, Issam
    Giralt, Sergio
    Mailankody, Sham
    Usmani, Saad
    Hashmi, Hamza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S46 - S46
  • [35] Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma
    Derman, Benjamin A.
    Parker, William F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (08): : 687 - 688
  • [36] Management of cytokine release syndrome after chimeric antigen T-cell therapy for paediatric relapsed/refractory acute lymphoblastic leukaemia: a case report
    Cheng, Frankie W. T.
    Li, Ben S.
    Lam, Grace K. S.
    Hon, K. L.
    Joynt, Gavin
    Li, C. K.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (06) : 532 - 534
  • [37] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Ding, Hong
    Wu, Yu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
  • [38] A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy
    Dai, Zigang
    Yu, Nanzhou
    Cao, Yang
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Zhou, Xiaoxi
    CYTOTHERAPY, 2025, 27 (03) : 295 - 299
  • [39] Teclistamab as monotherapy in patients with relapsed or refractory multiple myeloma who received three or more lines of therapy
    Le Grand, Sophie
    Karlin, Lionel
    BULLETIN DU CANCER, 2023, 110 (09) : 871 - 872
  • [40] Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naive in Relapsed/Refractory Multiple Myeloma
    Snyder, Jordan
    Graf, Kevin
    Davis, James A.
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Alkharabsheh, Omar
    Hashmi, Hamza
    Shaikh, Hira
    Lochner, Jonathan
    Chang, Darryl
    Atrash, Shebli
    Habib, Alma
    Venkatesh, Priyanka
    Mahmoudjafari, Zahra
    Ahmed, Nausheen
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Green, Kimberly M.
    Khan, Abdullah Mohammad
    BLOOD, 2024, 144 : 24117 - 24118